8182. Safety and efficacy of an intravenous loading dose of azathioprine for treatment of non-TPMT-deficient patients with rheumatic diseases.
作者: A Pickenpack.;R H Straub.;O Distler.;A Hammond.;M Oellerich.;J Schölmerich.;B Lang.;E Schütz.
来源: Rheumatology (Oxford). 2000年39卷12期1435-6页 8191. Lack of evidence for an association between hantavirus infections and Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and giant cell arteritis.
作者: P Gerke.;D Wichmann.;U Schönermarck.;M Schütt.;H Feldmann.;T G Ksiazek.;P M Rob.;W L Gross.
来源: Rheumatology (Oxford). 2000年39卷12期1424-5页 8194. Long-term observations of vertebral osteoporotic fractures treated by percutaneous vertebroplasty.
作者: F Grados.;C Depriester.;G Cayrolle.;N Hardy.;H Deramond.;P Fardellone.
来源: Rheumatology (Oxford). 2000年39卷12期1410-4页
To assess the immediate and long-term efficacy and safety of percutaneous vertebroplasty with polymethylmethacrylate (PMMA) for the treatment of refractory pain resulting from osteoporotic vertebral fractures.
8195. The impact of rheumatoid arthritis on employment status in the early years of disease: a UK community-based study.
To establish the prevalence of work disability and predictors of change in employment status in patients with early rheumatoid arthritis (RA).
8196. Giant cell arteritis is more prevalent in urban than in rural populations: results of an epidemiological study of primary systemic vasculitides in Germany.
作者: E Reinhold-Keller.;A Zeidler.;J Gutfleisch.;H H Peter.;H H Raspe.;W L Gross.
来源: Rheumatology (Oxford). 2000年39卷12期1396-402页
To investigate the period prevalences of primary systemic vasculitides (PSV) in urban and rural populations in northern and southern Germany in 1994.
8197. Rheumatology telephone helplines: an activity analysis. South and West of England Rheumatology Consortium.
作者: C McCabe.;J McDowell.;J Cushnaghan.;S Butts.;S Hewlett.;S Stafford.;J O'Hea.;A Breslin.
来源: Rheumatology (Oxford). 2000年39卷12期1390-5页
Anecdotal evidence suggests that the services offered by rheumatology telephone helplines in the UK vary widely between NHS Trusts because of the lack of national or European guidelines.
8198. Oral corticosteroids and fracture risk: relationship to daily and cumulative doses.
作者: T P van Staa.;H G Leufkens.;L Abenhaim.;B Zhang.;C Cooper.
来源: Rheumatology (Oxford). 2000年39卷12期1383-9页
This study examined the effects of daily and cumulative oral corticosteroid doses on the risk of fractures.
8199. Toxicity of anti-rheumatic drugs in a randomized clinical trial of early rheumatoid arthritis.
作者: C H van Jaarsveld.;Z N Jahangier.;J W Jacobs.;A A Blaauw.;G A van Albada-Kuipers.;E J ter Borg.;H L Brus.;Y Schenk.;M J van Der Veen.;J W Bijlsma.
来源: Rheumatology (Oxford). 2000年39卷12期1374-82页
To evaluate the toxicity of slow-acting anti-rheumatic drugs (SAARDs) and non-steroidal anti-inflammatory drugs (NSAIDs) in early rheumatoid arthritis.
8200. Evidence of cerebral hypoperfusion in scleroderma patients.
作者: M Cutolo.;F Nobili.;A Sulli.;C Pizzorni.;M Briata.;F Faelli.;P Vitali.;G Mariani.;F Copello.;B Seriolo.;C Barone.;G Rodriguez.
来源: Rheumatology (Oxford). 2000年39卷12期1366-73页
To investigate regional cerebral blood flow by (99m)Tc-hexamethylpropylenamineoxime (HMPAO) single photon emission computed tomography (SPECT) in a series of 40 patients (mean age 58.5+/-11.5 yr) affected by systemic sclerosis (SSc) in comparison with age-matched healthy controls.
|